Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer
NCT ID: NCT02375035
Last Updated: 2015-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2015-01-31
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate Biopsies
NCT03609528
Capture of Prostatic Trans-rectal Ultrasound Scans for Research
NCT03321864
Robot-Assisted MRI-Guided Prostate Biopsy
NCT02080052
Motorised Probe Holder Assisting Prostate Biopsies
NCT02132975
Ultrasound Based Transperineal Robotic Biopsy of the the Prostate
NCT01102361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To use data from the pilot study to determine the feasibility of a randomised trial comparing CAMPROBE with the current standard method of prostate biopsies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAMPROBE
To assess patient's experience and complications of the CAMPROBE biopsy needle and compare the results with known published outcomes from standard transrectal biopsies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men who have previously had a transrectal ultrasound biopsy of the prostate and due to have a repeat biopsy as part of normal care
* Men on active surveillance
* Men on PSA monitoring
Exclusion Criteria
* Contraindication for a transperineal prostate biopsies
* Previous perineal or anal surgery
* MRI suggesting anterior lesion or extra capsular disease
* MRI suggesting lesion that needs fusion image targeting
* Unable to lie down and with legs in a stirrup for at least 45 minutes
18 Years
85 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cambridge University Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vincent Gnanapragasam
Lecturer in Uro-oncology and Consultant Urological Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent Gnanapragasam
Role: PRINCIPAL_INVESTIGATOR
University of Cambridge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cambridge University Hospitals NHS Foundation Trust
Cambridge, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AO93224
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.